mRNA therapeutics market projected to reach $40.69 billion by 2028 driven by technology advancements
Summary: The mRNA therapeutics market is projected to grow from $33.5 billion in 2023 to $34.76 billion in 2024, with a compound annual growth rate of 3.8%. By 2028, it is expected to reach $40.69 billion, growing at 4% annually.
Key drivers of this growth include rising infectious diseases, increased hospital visits, and advancements in mRNA technology. Emerging self-amplifying mRNA platforms and improved manufacturing processes are expected to enhance vaccine development and flexibility in production.
North America remains the largest market, while Asia-Pacific is anticipated to be the fastest-growing region. Major companies in the sector include Pfizer, Moderna, and BioNTech, focusing on innovative mRNA-based vaccines and therapies.
This is article metrics. Combined, they form a significance score, that indicates how important the news is on a scale from 0 to 10.
My algorithm scores 10,000 news articles daily, and creates a single significance-ordered list of news.
Read more about how I calculate significance, or see today's top ranked news on the main page:
See today's news rankings